Literature DB >> 1665683

Late-onset congenital adrenal hyperplasia in a group of hyperandrogenic women.

D K Hassíakos1, J P Toner, G S Jones, H W Jones.   

Abstract

The aim of this study was to determine the prevalence of late-onset congenital adrenal hyperplasia (LOCAH) in a group of hyperandrogenic women presenting with menstrual disturbances and/or infertility. Thirty-five women were evaluated by basal hormonal profiles and underwent ACTH stimulation testing. In this study, 17.1% of women showed evidence of partial 21-OH deficiency (21-OHD), and 5.7% 3 beta-HSD deficiency. Neither basal hormonal levels nor clinical characteristics distinguished women with LOCAH from other hyperandrogenic women. And although the mean basal 17-OH progesterone (17-OHP) level in women with 21-OHD (152 +/- 66 ng/dl) was significantly higher than levels in other hirsute women, 4 of 6 (67%) women with 21-OHD had normal 17-OHP levels. Thus, to identify all affected individuals with partial 21-OHD, our data suggest that hyperandrogenic women with basal unsuppressed 17-OHP levels greater than 100 ng/dl should undergo dynamic testing. With regard to partial 3 beta-HSD deficiency, basal DHEA-S levels greater than the 95th percentile of other hirsute women may be used to screen for this deficiency. In conclusion, LOCAH due to partial steroid enzyme deficiencies are a frequent occurrence in women who present with symptoms of hyperandrogenism and ACTH stimulation remains an important tool in making the diagnosis of enzyme deficiencies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1665683     DOI: 10.1007/bf02390383

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  16 in total

Review 1.  Late onset congenital adrenal hyperplasia: a gynecologist's perspective.

Authors:  B L Brodie; A C Wentz
Journal:  Fertil Steril       Date:  1987-08       Impact factor: 7.329

2.  Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women.

Authors:  S Y Pang; A J Lerner; E Stoner; L S Levine; S E Oberfield; I Engel; M I New
Journal:  J Clin Endocrinol Metab       Date:  1985-03       Impact factor: 5.958

3.  Late-onset adrenal hyperplasia in hirsutism.

Authors:  F Kuttenn; P Couillin; F Girard; L Billaud; M Vincens; C Boucekkine; J C Thalabard; T Maudelonde; P Spritzer; I Mowszowicz
Journal:  N Engl J Med       Date:  1985-07-25       Impact factor: 91.245

4.  Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency.

Authors:  D Dewailly; M C Vantyghem-Haudiquet; C Sainsard; J Buvat; J P Cappoen; K Ardaens; A Racadot; J Lefebvre; P Fossati
Journal:  J Clin Endocrinol Metab       Date:  1986-08       Impact factor: 5.958

5.  Prevalence of and markers for the attenuated form of congenital adrenal hyperplasia and hyperprolactinemia masquerading as polycystic ovarian disease.

Authors:  F Benjamin; S Deutsch; H Saperstein; V L Seltzer
Journal:  Fertil Steril       Date:  1986-08       Impact factor: 7.329

6.  Late onset adrenal hyperplasia in a group of Irish females who presented with hirsutism, irregular menses and/or cystic acne.

Authors:  B McLaughlin; P Barrett; T Finch; J G Devlin
Journal:  Clin Endocrinol (Oxf)       Date:  1990-01       Impact factor: 3.478

7.  Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease.

Authors:  R A Lobo; U Goebelsmann
Journal:  Am J Obstet Gynecol       Date:  1980-11-15       Impact factor: 8.661

8.  Attenuated forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  P A Lee; Z Rosenwaks; M D Urban; C J Migeon; W D Bias
Journal:  J Clin Endocrinol Metab       Date:  1982-11       Impact factor: 5.958

9.  Abnormal adrenal responses to adrenocorticotropic hormone in hyperandrogenic women.

Authors:  M Gibson; R Lackritz; I Schiff; D Tulchinsky
Journal:  Fertil Steril       Date:  1980-01       Impact factor: 7.329

10.  Dexamethasone suppression test in the management of hyperandrogenized patients.

Authors:  G E Abraham; G B Maroulis; S P Boyers; J E Buster; D M Magyar; C W Elsner
Journal:  Obstet Gynecol       Date:  1981-02       Impact factor: 7.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.